Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications.

Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ; AIDS Seroepidemiology Collaborative Working Group, Gallo RC, Blattner WA.

JAMA. 2014 Jul 23-30;312(4):442. doi: 10.1001/jama.2013.279636. No abstract available.

PMID:
25038372
2.

Unsung hero Robert C. Gallo.

Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

Science. 2009 Jan 9;323(5911):206-7. doi: 10.1126/science.323.5911.206. No abstract available.

PMID:
19131607
3.

Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis.

Tözsér J, Shulenin S, Kádas J, Boross P, Bagossi P, Copeland TD, Nair BC, Sarngadharan MG, Oroszlan S.

Virology. 2003 May 25;310(1):16-23.

5.
6.

Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique.

Romano JW, Shurtliff RN, Sarngadharan MG, Pal R.

J Virol Methods. 1995 Aug;54(2-3):109-19.

PMID:
8530563
7.

Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals.

Devico AL, Rahman R, Sarngadharan MG, Veronese FD.

AIDS Res Hum Retroviruses. 1994 Aug;10(8):953-60.

PMID:
7529034
8.

Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.

Nair BC, Ford G, Kalyanaraman VS, Zafari M, Fang C, Sarngadharan MG.

J Clin Microbiol. 1994 Jun;32(6):1449-56.

9.

Glycoprotein of human immunodeficiency virus type 1 synthesized in chronically infected Molt3 cells acquires heterogeneous oligosaccharide structures.

Pal R, di Marzo Veronese F, Nair BC, Rittenhouse S, Hoke G, Mumbauer S, Sarngadharan MG.

Biochem Biophys Res Commun. 1993 Nov 15;196(3):1335-42.

PMID:
8250888
10.
11.

High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.

DeVico AL, Issel CJ, Le Grice SF, Payne SL, Montelaro RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1993 Jan;9(1):7-11.

PMID:
7678974
12.

Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.

di Marzo Veronese F, Rahman R, Pal R, Boyer C, Romano J, Kalyanaraman VS, Nair BC, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1125-32.

PMID:
1380259
13.

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC, Sarngadharan MG.

Science. 1992 Mar 13;255(5050):1430-2.

PMID:
1542792
14.

Reverse transcriptase--a general discussion.

DeVico AL, Sarngadharan MG.

J Enzyme Inhib. 1992;6(1):9-34. Review. No abstract available.

PMID:
1285305
15.

Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.

Pal R, di Marzo Veronese F, Nair BC, Rahman R, Hoke G, Mumbauer SW, Sarngadharan MG.

Intervirology. 1992;34(2):86-93.

PMID:
1284059
16.

Purification and partial characterization of equine infectious anemia virus reverse transcriptase.

DeVico A, Montelaro RC, Gallo RC, Sarngadharan MG.

Virology. 1991 Nov;185(1):387-94.

PMID:
1718086
17.

Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.

Pal R, Mumbauer S, Hoke GM, Takatsuki A, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1991 Aug;7(8):707-12.

PMID:
1718346
18.

Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.

Pal R, Mumbauer S, Hoke G, Larocca R, Myers C, Sarngadharan MG, Stein CA.

AIDS Res Hum Retroviruses. 1991 Jun;7(6):537-43.

PMID:
1718343
20.

Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer.

DeVico AL, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG.

J Biol Chem. 1991 Apr 15;266(11):6774-9.

21.

Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

Stein CA, Pal R, DeVico AL, Hoke G, Mumbauer S, Kinstler O, Sarngadharan MG, Letsinger RL.

Biochemistry. 1991 Mar 5;30(9):2439-44.

PMID:
1705817
22.

Differential viral gene expression and its effect on the biological properties of the cell clones of an HIV-1-infected cell line.

Kalyanaraman VS, Rodriguez V, Josephs S, Gallo RC, Sarngadharan MG.

Virology. 1990 Jul;177(1):380-3.

PMID:
2353462
23.

Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.

Pal R, Reitz MS Jr, Tschachler E, Gallo RC, Sarngadharan MG, Veronese FD.

AIDS Res Hum Retroviruses. 1990 Jun;6(6):721-30.

PMID:
2194551
24.

Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.

Kalyanaraman VS, Rodriguez V, Veronese F, Rahman R, Lusso P, DeVico AL, Copeland T, Oroszlan S, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1990 Mar;6(3):371-80.

PMID:
2187500
25.

Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.

Veronese FD, Rahman R, Kalyanaraman VS, Pal R, Lusso P, Tritch R, Petteway S, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1989 Oct;5(5):479-86.

PMID:
2480151
26.
27.

Identification of simian immunodeficiency virus SIVMAC env gene products.

Veronese FD, Joseph B, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG.

J Virol. 1989 Mar;63(3):1416-9.

28.

Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase.

DeVico AL, Copeland TD, Veronese FD, Oroszlan S, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1989 Feb;5(1):51-60.

PMID:
2470399
29.
30.
31.

A unique human immunodeficiency virus culture secreting soluble gp160.

Kalyanaraman VS, Pal R, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1988 Oct;4(5):319-29.

PMID:
3264172
32.

Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.

Hao Z, Cooney DA, Hartman NR, Perno CF, Fridland A, DeVico AL, Sarngadharan MG, Broder S, Johns DG.

Mol Pharmacol. 1988 Oct;34(4):431-5.

PMID:
2459590
33.

Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.

Veronese FD, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG.

J Virol. 1988 Mar;62(3):795-801.

34.

High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.

DeVico AL, Veronese FD, Lee SL, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1988 Feb;4(1):17-22.

PMID:
2452648
35.

Purification of envelope glycoproteins of human T cell lymphotropic virus type I (HTLV-I) by affinity chromatography.

Palker TJ, Clark ME, Sarngadharan MG, Matthews TJ.

J Virol Methods. 1987 Dec;18(4):243-55.

PMID:
2832431
36.

Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.

Manca N, di Marzo Veronese F, Ho DD, Gallo RC, Sarngadharan MG.

Eur J Epidemiol. 1987 Jun;3(2):96-102.

PMID:
3497054
37.

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.

Ho DD, Sarngadharan MG, Hirsch MS, Schooley RT, Rota TR, Kennedy RC, Chanh TC, Sato VL.

J Virol. 1987 Jun;61(6):2024-8.

38.

HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis.

Mann DL, DeSantis P, Mark G, Pfeifer A, Newman M, Gibbs N, Popovic M, Sarngadharan MG, Gallo RC, Clark J, et al.

Science. 1987 May 29;236(4805):1103-6.

PMID:
2883731
39.

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.

Mitsuya H, Jarrett RF, Matsukura M, Di Marzo Veronese F, DeVico AL, Sarngadharan MG, Johns DG, Reitz MS, Broder S.

Proc Natl Acad Sci U S A. 1987 Apr;84(7):2033-7.

40.

Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors.

Kaplan MH, Susin M, Pahwa SG, Fetten J, Allen SL, Lichtman S, Sarngadharan MG, Gallo RC.

Am J Med. 1987 Mar;82(3):389-96.

PMID:
3493690
41.

Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).

Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S.

J Am Acad Dermatol. 1987 Mar;16(3 Pt 1):485-506.

PMID:
2950145
42.

Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.

Cheng YC, Dutschman GE, Bastow KF, Sarngadharan MG, Ting RY.

J Biol Chem. 1987 Feb 15;262(5):2187-9.

43.

Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

Veronese FD, Rahman R, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG.

AIDS Res Hum Retroviruses. 1987 Fall;3(3):253-64.

PMID:
3481270
44.

Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection.

Laure F, Leonard R, Mbayo K, Lurhuma Z, Kayembe N, Brechot C, Sarin PS, Sarngadharan M, Wong-Staal F, Gallo RC, et al.

AIDS Res Hum Retroviruses. 1987;3(4):343-53.

PMID:
2451928
45.
46.

Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease.

Harper ME, Kaplan MH, Marselle LM, Pahwa SG, Chayt KJ, Sarngadharan MG, Wong-Staal F, Gallo RC.

N Engl J Med. 1986 Oct 23;315(17):1073-8. No abstract available.

PMID:
2876381
47.

Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years.

Frazer IH, Mackay IR, Crapper RM, Jones B, Gust ID, Sarngadharan MG, Campbell DC, Ungar B.

Q J Med. 1986 Oct;61(234):921-33.

PMID:
3498182
48.

Unusual features of scabies complicating human T-lymphotropic virus type III infection.

Sadick N, Kaplan MH, Pahwa SG, Sarngadharan MG.

J Am Acad Dermatol. 1986 Sep;15(3):482-6.

PMID:
3760272
49.

Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Blumberg RS, Sandstrom EG, Paradis TJ, Neumeyer DN, Sarngadharan MG, Hartshorn KL, Byington RE, Hirsch MS, Schooley RT.

J Clin Microbiol. 1986 Jun;23(6):1072-7.

50.

Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.

Pahwa S, Kaplan M, Fikrig S, Pahwa R, Sarngadharan MG, Popovic M, Gallo RC.

JAMA. 1986 May 2;255(17):2299-305.

PMID:
3007791

Supplemental Content

Loading ...
Support Center